AN2 Therapeutics, Inc.AN2 Therapeutics, Inc.AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc.

No trades
See on Supercharts

Price target

2.670.000.00%
The 3 analysts offering 1 year price forecasts for ANTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to ANTX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ANTX EPS for the last quarter is −0.43 USD despite the estimation of −0.45 USD. In the next quarter EPS is expected to reach −0.27 USD. Track more of AN2 Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter AN2 Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out AN2 Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, ANTX price target is 2.67 USD with a max estimate of 5.00 USD and a min estimate of 1.00 USD. Check if this forecast comes true in a year, meanwhile watch AN2 Therapeutics, Inc. stock price chart and keep track of the current situation with ANTX news and stock market news.
We've gathered opinions of 5 analysts rating ANTX stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.